Chimerism does not predict for outcome after alemtuzumab based conditioning. Bone Marrow Transplant 2007 Jul;40(2):181
Date
05/16/2007Pubmed ID
17502895DOI
10.1038/sj.bmt.1705707Scopus ID
2-s2.0-34447284249 (requires institutional sign-in at Scopus site) 7 CitationsAuthor List
Michaelis L, Lin S, Joseph L, Artz AS, Kline J, Pollyea D, Stock W, Rich E, Collins-Jones D, Casey B, Del Cerro P, van Besien KAuthor
Laura Michaelis MD Chief, Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AlemtuzumabAntibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antibodies, Neoplasm
Graft vs Host Disease
Hematologic Neoplasms
Humans
Stem Cell Transplantation
Transplantation Chimera
Transplantation Conditioning
Transplantation, Homologous
Treatment Outcome